circHIPK3 promotes pro-fibrotic epithelial reprogramming via the miR-29a-3p/SPARC axis with associated enhancement of TGF-β/SMAD signaling

Curcumin regulates pulmonary extracellular matrix remodeling and mitochondrial function to attenuate pulmonary fibrosis by regulating the miR-29a-3p/DNMT3A axis

10.1016/j.biopha.2024.116572 · doi-reference

MiR-29a-3p inhibits fibrosis of diabetic kidney disease in diabetic mice via downregulation of DNA methyl transferase 3A and 3B

10.4239/wjd.v16.i4.93630 · doi-reference

Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control

10.1128/jvi.02202-17 · doi-reference

The multilayered complexity of ceRNA crosstalk and competition

10.1038/nature12986 · doi-reference

A lung targeted miR-29 mimic as a therapy for pulmonary fibrosis

10.1016/j.ebiom.2022.104304 · doi-reference

MicroRNA mimicry blocks pulmonary fibrosis

10.15252/emmm.201303604 · doi-reference

Transcriptional profiling of insulin-like growth factor signaling components in embryonic lung development and idiopathic pulmonary fibrosis

10.3390/cells11121973 · doi-reference

MicroRNA therapeutics: towards a new era for the management of cancer and other diseases

10.1038/nrd.2016.246 · doi-reference

SPARC, a matricellular protein: at the crossroads of cell-matrix

10.1016/s0945-053x(00)00105-0 · doi-reference

Pten regulates collagen fibrillogenesis by fibroblasts through SPARC

10.1371/journal.pone.0245653 · doi-reference

The role of SPARC in extracellular matrix assembly

10.1007/s12079-009-0062-6 · doi-reference

Secreted protein acidic and rich in cysteine (SPARC) is upregulated by transforming growth factor (TGF)-β and is required for TGF-β-induced hydrogen peroxide production in fibroblasts

10.1186/1755-1536-6-6 · doi-reference

SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells

10.1002/jcb.20008 · doi-reference

Lack of the matricellular protein SPARC (secreted protein, acidic and rich in cysteine) attenuates liver fibrogenesis in mice

10.1371/journal.pone.0054962 · doi-reference

SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury

10.1172/jci12939 · doi-reference

The role of miR-29 family in TGF-β driven fibrosis in glaucomatous optic neuropathy

10.3390/ijms231810216 · doi-reference

Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an Official ATS/ERS/JRS/ALAT Clinical Practice guideline

10.1164/rccm.202202-0399st · doi-reference

Loss of PTEN induces lung fibrosis via alveolar epithelial cell senescence depending on NF-κB activation

10.1111/acel.12858 · doi-reference

Time and phenotype-dependent transcriptome analysis in AAV-TGFβ1 and Bleomycin-induced lung fibrosis models

10.1038/s41598-022-16344-7 · doi-reference

Reticulocalbin 3 deficiency in alveolar epithelium exacerbated bleomycin-induced pulmonary fibrosis

10.1165/rcmb.2017-0347oc · doi-reference

The bleomycin model of pulmonary fibrosis

10.1007/978-1-4939-7113-8_2 · doi-reference

Endothelial cell-derived MMP19 promotes pulmonary fibrosis by inducing E(nd)MT and monocyte infiltration

10.1186/s12964-023-01040-4 · doi-reference

Highly selective Endothelin-1 receptor A inhibition prevents bleomycin-induced pulmonary inflammation and fibrosis in mice

10.1159/000481201 · doi-reference

IL-17A deficiency mitigates bleomycin-induced complement activation during lung fibrosis

10.1096/fj.201700289r · doi-reference

The SPARC protein: an overview of its role in lung cancer and pulmonary fibrosis and its potential role in chronic airways disease

10.1111/bph.13653 · doi-reference

SPARC suppresses apoptosis of idiopathic pulmonary fibrosis fibroblasts through constitutive activation of beta-catenin

10.1074/jbc.m109.025684 · doi-reference

miR-29 inhibits bleomycin-induced pulmonary fibrosis in mice

10.1038/mt.2012.36 · doi-reference

Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis

10.1002/hep.23922 · doi-reference

miR-29 is a major regulator of genes associated with pulmonary fibrosis

10.1165/rcmb.2010-0323oc · doi-reference

Exosomal circHIPK3 released from hypoxia-pretreated cardiomyocytes regulates oxidative damage in cardiac Microvascular endothelial cells via the miR-29a/IGF-1 pathway

10.1155/2019/7954657 · doi-reference

CircHIPK3 regulates pulmonary fibrosis by facilitating glycolysis in miR-30a-3p/FOXK2-dependent manner

10.7150/ijbs.57915 · doi-reference

circHIPK3 regulates lung fibroblast-to-myofibroblast transition by functioning as a competing endogenous RNA

10.1038/s41419-019-1430-7 · doi-reference

Inhibition of circHIPK3 prevents angiotensin II-induced cardiac fibrosis by sponging miR-29b-3p

10.1016/j.ijcard.2019.04.006 · doi-reference

Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs

10.1038/ncomms11215 · doi-reference

Circ_0000064 promotes high glucose-induced renal tubular epithelial cells injury to facilitate diabetic nephropathy progression through miR-532-3p/ROCK1 axis

10.1186/s12902-022-00968-x · doi-reference

Circular RNAs are a large class of animal RNAs with regulatory potency

10.1038/nature11928 · doi-reference

The function of non-coding RNAs in idiopathic pulmonary fibrosis

10.1515/med-2021-0231 · doi-reference

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis

10.1056/nejmoa1402584 · doi-reference

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis

10.1056/nejmoa1402582 · doi-reference

Pathogenic mechanisms underlying idiopathic pulmonary fibrosis

10.1146/annurev-pathol-042320-030240 · doi-reference